Suki
Suki develops AI software that helps clinicians document visits and healthcare technology vendors embed clinical assistance in their products.
$90MSeries E
ParticipantCC
Crosslink Capital
Activity from announced rounds
Activity in this selectionOct 24, 2026 · Healthtech · Jan 1, 2026
Crosslink Capital is an investment firm whose own portfolio news identifies Yardstik, RockRose Risk and Intermezzo.
Recorded funding activity
Yardstik combines fraud prevention, background screening and workforce monitoring. RockRose links wildfire mitigation with property insurance, while Intermezzo supplies international payroll APIs. The covered financings connect these distinct products to the same firm-level investor.
Sources
- Rounds participated in
- 3
- Confirmed lead rounds
- 0 2 roles undisclosed
- New companies
- 3 First participation on record · 0 follow-on
- Funding in participating rounds
- $117M 3 disclosed · full round size, not this investor’s share